期刊文献+

肝豆状核变性与慢性乙型肝炎重度患者临床特征分析 被引量:1

Clinical features of patients with Wilson's disease and hyperbilirubinemia: Comparison to patients with chronic hepatitis B of severe degree
下载PDF
导出
摘要 目的观察肝豆状核变性(WD)伴黄疸患者的临床特征,探讨肝豆状核变性黄疸患者临床鉴别诊断的侧重点。方法回顾性分析52例以"黄疸待查"初次入院的WD患者的临床资料,包括临床表现和常规实验室指标的变化。采用序列分析法检测全血基因组8、12、13、16外显子的突变情况。结果本研究纳入WD患者24例和慢性乙型肝炎重度患者28例。WD患者发病中位年龄(33.2岁)显著低于乙型肝炎(41.8岁,P=0.049),WD患者自起病至明确诊断的中位时间(8.2月)显著长于乙型肝炎(1月,P<0.001);WD患者24 h尿铜水平(919.83±1017.15μg)显著高于乙型肝炎(204.79±191.85μg,P<0.001);WD患者血清γ-谷氨酰转肽酶水平(175.74±245.99U/L)显著高于乙型肝炎(133.44±115.95 U/L,P=0.004),且与24 h尿铜水平呈正相关(r=0.552,P=0.012);24例WD患者全部,而仅4例乙型肝炎患者可检出ATP7B突变。结论肝豆状核变性伴黄疸患者除可利用血清铜、铜蓝蛋白检测进行筛选性诊断外,24 h尿铜检测为重要的鉴别诊断指标,而血清γ-谷氨酰转肽酶可能是该病潜在的诊断指标。 Objective To explore the clinical features of patients with Wilson’s disease and hyperbiliru-binemia. Method Twenty-four patients with Wilson’s disease and twenty-eight with chronic hepatitis B of severe degree were included in this study. The manifestation and routine laboratory tests were collected. The peripheral blood ATP7B gene mutations in exon 8,12,13 and 16 were analyzed by direct sequencing. Results The pa-tients with WD had the features of significantly younger (33.2 vs. 41.8 yr old,P=0.049),longer delay diagnosis time (8.2 vs. 1 month,P&lt;0.001) as compared to patients with hepatitis B;the total urine copper in 24 hours was significantly elevated [(919.83±1017.15)μg vs. (204.79±191.85)μg,P〈0.001];the patients with WD had signifi-cantly higher serum glutamyltranspeptidase level [(175.74±245.99) U/L] as compared with in patients with hepati-tis B[(133.44±115.95) U/L,P=0.004],which had a positive correlation with 24 hours total urine copper drainage (r=0.552,P=0.012);all the patients with WD were positive for ATP7B mutation,while only 4 patients with hep-atitis B positive. Conclusion Serum copper and ceruloplasmin levels may be useful for screening patients with WD and jaundice,and the 24 hour urine copper excretion is an important index for differential diagnosis from se-vere chronic hepatitis B.
出处 《实用肝脏病杂志》 CAS 2015年第5期486-490,共5页 Journal of Practical Hepatology
基金 华中科技大学自主创新基金重点项目(编号:2013ZHYX004)
关键词 肝豆状核变性 黄疸 临床特征 鉴别诊断 Wilson’s Disease Hyperbilirubinemia Clinical features Differential diagnosis
  • 相关文献

参考文献21

  • 1Roberts EA,Schilsky ML. American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease:an update. Hepatology,2008,47(6):2089-2111.
  • 2Medici V,Rossaro L,Stumiolo GC. Wilson disease-a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis, 2007,39(7 ):601-609.
  • 3Shah D. Wilson's disease:hepatic manifestations. Dis Mon, 2014,60(9):465-474.
  • 4Dalvi A. Wilson's disease:neurological and psychiatric manifes- tations. Dis Mon,2014,60(9):460-464.
  • 5Dalvi A,Padmanahan M. Wilson's disease:etiology,diagnosis, and treatment. Dis Mon,2014,60(9):450-459.
  • 6S chilsky ML. Wilson disease:current status and the future Biochimie,2009,91( 10):1278-1281.
  • 7Ala A,Schilsky ML. Wilson disease:pathophysiology,diagnosis, treatment,and screening. Clin Liver Dis,2004,8(4):787-805,viii.
  • 8无.肝豆状核变性的诊断与治疗指南[J].中华神经科杂志,2008,41(8):566-569. 被引量:260
  • 9慢性乙型肝炎防治指南(2010年版)[J].实用肝脏病杂志,2011,14(2):81-89. 被引量:436
  • 10Liu Y,Zhou H,Guo H,et al. Genetic and clinical analysis in a cohort of patients with Wilson's Disease in Southwestern China. Arch Med Res,2015,19. pii:S0188-4409.

二级参考文献25

  • 1梁秀龄,陈曦,李洵桦,黄丽,石铸,汤其强.肝豆状核变性临床若干问题[J].中华神经科杂志,2005,38(1):57-59. 被引量:54
  • 2Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet, 2007, 369:397-405.
  • 3Figus A, Angius A, Loudianos G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet, 1995, 57: 1318-1324.
  • 4Roberts EA, Schilsky ML; Division Gastroenterology and Nutrition. A practice guideline on Wilson disease. Hepatology, 2003, 37 : 1475-1492.
  • 5Wilson DC ,Phillips M J, Cox DW, et al. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr, 2000, 137: 719- 722.
  • 6Ala A, Borjigin J, Rochwarger A, et al. Wilson disease in septuagenarian siblings : Raising the bar for diagnosis. Hepatology, 2005, 41:668-670.
  • 7Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int, 2003,23 : 139-142.
  • 8Sinha S ,Taly AB. Withdrawal of peniciUamine from zinc sulphatepenicillamine maintance therapy in Wilson's disease : promising, safe and cheap. J Neurol Sci, 2008,264: 129-132.
  • 9Brewer GJ, Hedera P, Khin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: Ⅲ. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol, 2003,60: 379-385.
  • 10Brewer GJ. Novel therapeutic approaches to the treatment of Wilson's disease. Expert Opin Pharmacother, 2006, 7: 317-324.

共引文献697

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部